Does ONC-392 Cause Immune-mediated enterocolitis? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Immune-mediated enterocolitis have been filed in association with ONC-392. This represents 29.6% of all adverse event reports for ONC-392.
8
Reports of Immune-mediated enterocolitis with ONC-392
29.6%
of all ONC-392 reports
1
Deaths
8
Hospitalizations
How Dangerous Is Immune-mediated enterocolitis From ONC-392?
Of the 8 reports, 1 (12.5%) resulted in death, 8 (100.0%) required hospitalization.
Is Immune-mediated enterocolitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ONC-392. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does ONC-392 Cause?
What Other Drugs Cause Immune-mediated enterocolitis?
NIVOLUMAB (1,289)
IPILIMUMAB (988)
PEMBROLIZUMAB (858)
CARBOPLATIN (307)
PACLITAXEL (188)
DURVALUMAB (165)
ATEZOLIZUMAB (156)
LENVATINIB (143)
PEMETREXED (129)
BEVACIZUMAB (92)